Related Experiment Videos
Generation and iterative affinity maturation of antibodies in vitro using hypermutating B-cell lines
Sarah J Cumbers1, Gareth T Williams, Sarah L Davies
1Medical Research Laboratory of Biology, Hills Road, Cambridge CB2 2QH, UK.
Nature Biotechnology
|October 16, 2002
Summary
Researchers developed a method to generate high-affinity antibodies in vitro using hypermutating B-cell lines. This technique exploits natural mutation processes for antibody maturation, offering a new tool for antibody generation.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- B-cell lines with constitutive immunoglobulin V gene hypermutation can be cultured in vitro.
- Generating antigen-specific antibodies with high affinity is crucial for therapeutic and diagnostic applications.
Purpose of the Study:
- To demonstrate the utility of iterative antigen-mediated selection of hypermutating B-cell lines for in vitro antibody generation.
- To explore the role of complementarity-determining regions (CDRs) and framework mutations in antibody affinity maturation.
Main Methods:
- Utilized Ramos (human B-cell line) and a hypermutating chicken B-lymphoma line for antibody selection.
- Employed iterative antigen-mediated selection to drive stepwise improvement in antibody binding affinity.
- Analyzed mutations in CDRs and framework regions contributing to antibody maturation.
Main Results:
- Derived B-cell descendants with stepwise improved binding to streptavidin, initially via CDR mutations and later framework mutations.
- Successfully generated mutated antibodies with increasing affinity to independent test antigens from a single chicken B-lymphoma cell.
- Achieved nanomolar affinities for selected antibodies, starting from an exceedingly low initial affinity threshold.
Conclusions:
- Iterative antigen-mediated selection of hypermutating B-cell lines is an effective strategy for in vitro generation of antigen-specific monoclonal antibodies.
- The method is extendable to the maturation of other protein-ligand interactions.
- Framework mutations play a strategic role in antibody affinity maturation alongside CDR mutations.